By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor Reports Top-line XmAb®5871 Phase 1b/2a Results Showing Promising Clinical Activity In Rheumatoid Arthritis 1/29/2015 7:28:44 AM
XencorReports XmAb®7195 Top-line Interim Phase 1a Results Showing Rapid Reduction Of Serum Ige In Healthy Volunteers 1/29/2015 7:26:03 AM
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S (NVO) 12/18/2014 6:13:06 AM
MorphoSys AG And Xencor Publish Final Results From Phase 1/2a Trial Of MOR208 (Xmab5574) In CLL/SLL At Xencor Annual Meeting 12/8/2014 7:40:19 AM
Xencor To Present At The 25th Annual Oppenheimer Healthcare Conference 12/5/2014 12:56:57 PM
Xencor To Present At The 2014 Deutsche Bank (DB) BioFEST Conference 11/25/2014 11:59:09 AM
Xencor Reports Third Quarter 2014 Financial Results 11/11/2014 7:40:47 AM
Xencor Provides Data Updates On XmAb Bispecific Antibody Programs And Announces Presentations At Upcoming American Society of Hematology 2014 Annual Meeting 11/6/2014 9:13:54 AM
Xencor To Present At The 2014 Credit Suisse Annual Healthcare Conference 11/4/2014 9:02:58 AM
Xencor To Host Third Quarter 2014 Financial Results Webcast And Conference Call 11/3/2014 7:37:26 AM